PortfoliosLab logoPortfoliosLab logo
InfuSystem Holdings Inc. (INFU)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US45685K1025
CUSIP
45685K102
IPO Date
Dec 27, 2007

Highlights

Market Cap
$194.44M
Enterprise Value
$194.68M
EPS (TTM)
$0.45
PE Ratio
20.39
PEG Ratio
0.02
Total Revenue (TTM)
$143.44M
Gross Profit (TTM)
$80.30M
EBITDA (TTM)
$21.96M
Year Range
$4.61 - $11.04
Target Price
$15.00
ROA (TTM)
9.50%
ROE (TTM)
16.66%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in InfuSystem Holdings Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

InfuSystem Holdings Inc. (INFU) has returned 2.90% so far this year and 71.56% over the past 12 months. Over the last ten years, INFU has returned 10.21% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


InfuSystem Holdings Inc.

1D
-1.28%
1M
5.25%
YTD
2.90%
6M
-10.91%
1Y
71.56%
3Y*
6.00%
5Y*
-15.01%
10Y*
10.21%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Dec 27, 2007, INFU's average daily return is +0.09%, while the average monthly return is +1.61%. At this rate, your investment would double in approximately 3.6 years.

Historically, 48% of months were positive and 52% were negative. The best month was Aug 2025 with a return of +92.5%, while the worst month was Sep 2011 at -37.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, INFU closed higher 42% of trading days. The best single day was Mar 26, 2009 with a return of +41.7%, while the worst single day was Nov 7, 2016 at -38.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-7.92%6.17%5.25%2.90%
2025-4.26%-1.36%-32.58%-12.27%22.46%7.96%-10.26%92.50%-3.90%0.00%-10.42%-3.34%6.15%
2024-12.43%0.22%-7.35%-12.37%-4.93%-4.34%1.02%-3.62%0.75%-7.61%43.78%-5.06%-19.83%
202315.44%-6.29%-17.47%20.90%-6.62%10.06%7.17%-0.39%-6.23%-0.62%4.70%5.08%21.43%
2022-11.33%-23.91%-14.71%-19.08%21.94%-0.41%1.45%-21.08%-9.34%9.16%12.45%1.17%-49.03%
2021-6.18%-3.18%19.34%11.10%-18.21%12.38%-12.22%-21.92%-8.56%27.63%-0.48%2.90%-9.32%

Benchmark Metrics

InfuSystem Holdings Inc. has an annualized alpha of 18.51%, beta of 0.47, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since December 28, 2007.

  • This stock participated in 84.74% of S&P 500 Index downside but only 70.80% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.47 may look defensive, but with R² of 0.03 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
18.51%
Beta
0.47
0.03
Upside Capture
70.80%
Downside Capture
84.74%

Return for Risk

Risk / Return Rank

INFU ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


INFU Risk / Return Rank: 7979
Overall Rank
INFU Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
INFU Sortino Ratio Rank: 8282
Sortino Ratio Rank
INFU Omega Ratio Rank: 7676
Omega Ratio Rank
INFU Calmar Ratio Rank: 7878
Calmar Ratio Rank
INFU Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for InfuSystem Holdings Inc. (INFU) and compare them to a chosen benchmark (S&P 500 Index).


INFUBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.32

0.90

+0.43

Sortino ratio

Return per unit of downside risk

2.25

1.39

+0.86

Omega ratio

Gain probability vs. loss probability

1.26

1.21

+0.05

Calmar ratio

Return relative to maximum drawdown

2.21

1.40

+0.81

Martin ratio

Return relative to average drawdown

5.43

6.61

-1.18

Explore INFU risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


InfuSystem Holdings Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the InfuSystem Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the InfuSystem Holdings Inc. was 79.49%, occurring on May 6, 2025. The portfolio has not yet recovered.

The current InfuSystem Holdings Inc. drawdown is 59.73%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.49%May 4, 20211007May 6, 2025
-78.33%Feb 4, 2008935Oct 17, 2011761Oct 27, 20141696
-69.7%Oct 28, 2014644May 18, 2017457Mar 14, 20191101
-51.49%Feb 21, 202019Mar 18, 202021Apr 17, 202040
-19.84%Apr 22, 202017May 14, 202059Aug 7, 202076

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of InfuSystem Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how InfuSystem Holdings Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for INFU, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/E ratio of 20.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for INFU compared to other companies in the Medical Instruments & Supplies industry. INFU currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for INFU relative to other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for INFU in comparison with other companies in the Medical Instruments & Supplies industry. Currently, INFU has a P/B value of 3.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items